Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - PRE-TAX INCOME
Pre-tax Income ALNY - Alnylam Pharmaceuticals, Inc.
-434 M
LAST VALUE
28.67%
2 YEAR CAGR
10.64%
5 YEAR CAGR
-16.78%
10 YEAR CAGR